Jpmorgan Chase & CO Sight Sciences, Inc. Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
A detailed history of Jpmorgan Chase & CO transactions in Sight Sciences, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 16,002 shares of SGHT stock, worth $74,569. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,002
Previous 973,917
98.36%
Holding current value
$74,569
Previous $5.14 Million
97.94%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding SGHT
# of Institutions
74Shares Held
21.4MCall Options Held
30.7KPut Options Held
18.6K-
Kck Ltd. Tortola, D84.65MShares$21.7 Million22.26% of portfolio
-
Bank Of America Corp Charlotte, NC3.15MShares$14.7 Million0.0% of portfolio
-
Ubs Group Ag2.86MShares$13.3 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.12MShares$9.88 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.65MShares$7.67 Million0.0% of portfolio
About Sight Sciences, Inc.
- Ticker SGHT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,826,200
- Market Cap $223M
- Description
- Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; a...